These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18436737)

  • 1. Bugs versus drugs: addressing the pharmacist's challenge.
    Burgess DS; Rapp RP
    Am J Health Syst Pharm; 2008 May; 65(9 Suppl 2):S4-15. PubMed ID: 18436737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials.
    Thabit AK; Crandon JL; Nicolau DP
    Expert Opin Pharmacother; 2015 Feb; 16(2):159-77. PubMed ID: 25496207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistant gram-negative bacilli: A neglected healthcare crisis?
    Lautenbach E; Polk RE
    Am J Health Syst Pharm; 2007 Dec; 64(23 Suppl 14):S3-21; quiz S22-4. PubMed ID: 18029939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
    Ramsamy Y; Muckart DJ; Han KS
    S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Need and potential of antimicrobial stewardship in community hospitals.
    Septimus EJ; Owens RC
    Clin Infect Dis; 2011 Aug; 53 Suppl 1():S8-S14. PubMed ID: 21795728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Extended spectrum beta lactamase forming pathogens (ESBL)].
    Gastmeier P
    Med Klin Intensivmed Notfmed; 2012 Nov; 107(8):592-3. PubMed ID: 23138656
    [No Abstract]   [Full Text] [Related]  

  • 7. Bugs versus drugs: what is the pharmacist's challenge?
    Nicolau DP
    Am J Health Syst Pharm; 2008 May; 65(9 Suppl 2):S2-3. PubMed ID: 18436736
    [No Abstract]   [Full Text] [Related]  

  • 8. Increasing prevalence of antimicrobial resistance among organisms isolated from blood culture in a Singapore hospital.
    Kumarasinghe G; Chow C; Yin LH; Hong SY; Bassett DC
    Southeast Asian J Trop Med Public Health; 1994 Mar; 25(1):116-22. PubMed ID: 7825001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combating antimicrobial resistance and healthcare-associated infections: the role of the Specialist Advisory Committee on Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI), 2007-2011. Preface.
    Lord Soulsby of Swaffham Prior
    J Antimicrob Chemother; 2012 Jul; 67 Suppl 1():i1. PubMed ID: 23029664
    [No Abstract]   [Full Text] [Related]  

  • 10. [Update of antimicrobial resistance in Gram-positive microorganisms].
    Cercenado E
    Med Clin (Barc); 2010 Dec; 135 Suppl 3():10-5. PubMed ID: 21477699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiresistant Gram-negative infections: a global perspective.
    Ho J; Tambyah PA; Paterson DL
    Curr Opin Infect Dis; 2010 Dec; 23(6):546-53. PubMed ID: 20802331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infections, bacterial resistance, and antimicrobial stewardship: the emerging role of hospitalists.
    Rosenberg DJ
    J Hosp Med; 2012; 7 Suppl 1():S34-43. PubMed ID: 23737336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial consumption, costs and resistance patterns: a two year prospective study in a Romanian intensive care unit.
    Axente C; Licker M; Moldovan R; Hogea E; Muntean D; Horhat F; Bedreag O; Sandesc D; Papurica M; Dugaesescu D; Voicu M; Baditoiu L
    BMC Infect Dis; 2017 May; 17(1):358. PubMed ID: 28532467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogen profile and drug resistance analysis of spontaneous peritonitis in cirrhotic patients.
    Li YT; Yu CB; Huang JR; Qin ZJ; Li LJ
    World J Gastroenterol; 2015 Sep; 21(36):10409-17. PubMed ID: 26420967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formula to help select rational antimicrobial therapy (FRAT): its application to community- and hospital-acquired urinary tract infections.
    Blondeau JM; Tillotson GS
    Int J Antimicrob Agents; 1999 Jul; 12(2):145-50. PubMed ID: 10418760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infections, bacterial resistance, and antimicrobial stewardship: the emerging role of hospitalists.
    Rosenberg DJ
    J Hosp Med; 2012; 7 Suppl 1():S34-43. PubMed ID: 23677633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological factors influencing the emergence of antimicrobial resistance.
    Cohen ML
    Ciba Found Symp; 1997; 207():223-31; discussion 231-7. PubMed ID: 9189644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiresistant Organisms].
    Hagel S; Stallmach A; Keller P; Pletz M
    Zentralbl Chir; 2015 Aug; 140(4):417-25. PubMed ID: 23824619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for improving antimicrobial use and the role of antimicrobial stewardship programs.
    File TM; Solomkin JS; Cosgrove SE
    Clin Infect Dis; 2011 Aug; 53 Suppl 1():S15-22. PubMed ID: 21795724
    [No Abstract]   [Full Text] [Related]  

  • 20. Developments in antimicrobial resistance and treatment.
    Bryan J
    Future Microbiol; 2011 Jul; 6(7):715-20. PubMed ID: 21797685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.